Real Time Chart
Stock Profile
Stock Fundamentals
Symbol Info
Symbol Over View
Technical Analysis

NVO stock profile

Overview
Insider summary
Insider transactions

Novo Nordisk Company Profile

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries, and affiliates or offices in five countries.

NVO stock profile

Novo Nordisk Company Profile

Company information

Peers

Top Executives

Related News

AMLP ETF: 8% Yield, Energy Infrastructure Surge, Buy Signal Ahead

NASDAQ:EYE Stock Price Forecast: Turnaround Gains Push Toward $40 Target

JD.com NASDAQ:JD Stock Price Forecast: Deep Value Play With $70 Target Potential

Novo Nordisk Stock Forecast - A Pharma Leader (NYSE:NVO) Undervalued as Growth Surges

Nvidia Stock Forecast: NASDAQ:NVDA Targets $204 as AI Megacycle Fuels Explosive Growth

Stock Market Update for the Upcoming Week: Dow at 45,631, S&P 500 Near Record, Nvidia Earnings Loom

News on the web

‘Time to Double Down,’ Says Top Investor About Novo Nordisk Stock

Novo Nordisk Executive Share Sale Disclosed

Novo Nordisk’s Stock Soars Amid Strategic Moves

“Expanding Horizons”: Hims & Hers (HIMS) Brings Affordable Weight Loss Program to Canada

Novo Nordisk Stock (NVO) Inches Higher Despite More U.K. Weight Jab Concerns

Hims & Hers Stock (HIMS) Collapses 30% After Novo Nordisk Pulls Wegovy Deal on Safety Fears

Hims & Hers Stock (HIMS) Loses Weight as Analysts Call for Insurance Pivot

Novo Nordisk (NVO) Signs $2.2B Deal to Develop Weight-Loss Pills

Eli Lilly Stock (LLY) Falls on Reports Novo Nordisk Is Developing New Obesity Treatments

Novo Nordisk’s Stock Soars Amid Wegovy Pill Hopes

Clinical Trial Success Positions Eli Lilly Stock (LLY) for Major Rebound

Novo Nordisk Faces Stock Dip Amidst Market Challenges

Is Pfizer Stock (PFE) Worth Buying After Its Weight Loss Pill Failure?

Ex-Dividend Date Nearing for These 10 Stocks – Week of March 31, 2025

Germany’s SAP (SAP) Is Now Europe’s Largest Publicly Traded Company

Novo Nordisk Stock (NVO) Plunges as It Shells Out $2 Billion on Chinese Weight Drug

Novo Nordisk Executives Report Share Transactions in Compliance with Market Regulations

Novo Nordisk Concludes Phase of Share Repurchase Program

Novo Nordisk Continues Aggressive Share Repurchase Programme

Novo Nordisk (NYSE:NVO) Slides as Weight-Loss Drug Trial Misses Expectations

Novo Nordisk Announces Major Share Buyback Program

NVO Earnings: Novo Nordisk Exceeds Q3 Earnings, Narrows Outlook

Novo Nordisk Completes DKK 2.4 Billion Share Buyback

Novo Nordisk’s Obesity Drug Shows Promise in Trial

Novo Nordisk Executives Buy Company Shares

Novo Nordisk Advances Share Buyback Initiative

Novo Nordisk Initiates Multi-Billion Share Buyback

Is Berkshire Hathaway (NYSE:BRK.B) Missing Out on AI Tailwinds?

Novo Nordisk Initiates Major Share Buy-Back Program

European Stocks: Novo Nordisk Bets Big to Lead the Weight-Loss Market

Pfizer Sets Sight on Obesity Market with Weight Loss Pill

Novo Nordisk Advances Share Repurchase Plan

Novo Nordisk Launches Major Share Buyback

Novo Nordisk: Genetic Profile Predicts Success with Wegovy

Novo Nordisk Executive Reports Share Sale

Novo Nordisk Launches Massive Share Buyback

VGK vs. EZU: Which Is the Better European Stock ETF?

Novo Nordisk Initiates Multi-Billion Share Buyback

Major Stocks Scale New Highs as Indices Set New Records

Novo Nordisk’s (NYSE:NVO) Wegovy Set to Storm China’s Weight Loss Market

Novo Nordisk’s (NYSE:NVO) Ozempic Shows Promise in Lowering Risk of Kidney Disease Progression

Weight Loss Drugs Are Slimming Down Grocery Bills

M & A News: Novo Nordisk Announces $16.5B Catalent (NYSE:CTLT) Deal, Shares Surge

New Environmental / Social Risk for Novo Nordisk – What’s the Latest?

Novo Nordisk (NYSE:NVO) Reaches New High on Robust Q4 Performance

GLP-1 Anti-Obesity Drugs: Slim Waistlines, Fat Profits

Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys” – 1/15/2024

TipRanks’ ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Poised to Perform in 2024

Gen Z Stocks: The Path from Gambling to Investment

Eli Lilly (NYSE:LLY) Slips as Zepbound Issues Grow

ABBV, NVO, or LLY: Which Healthcare Stock Could Generate the Highest Returns?

Eli Lilly’s (NYSE:LLY) Obesity Treatment Enters the U.S. Market

Novo Nordisk (NYSE:NVO) Falls as Large Investor Offloads Shares

Novo Nordisk (NYSE:NVO) Set to Introduce Wegovy in Asia

Novo Nordisk (NYSE:NVO) Pours $2.3B into Expanding Production in France

Up 65% YTD, Is Eli Lilly (NYSE:LLY) Stock Worth Buying?

Novo Nordisk’s (NYSE:NVO) Wegovy Data Sparks Investor Excitement

Novo Nordisk (NYSE:NVO) to Expand Production with $6B Investment

Eli Lilly (NYSE:LLY) Awaits UK Nod on Pen for Weight Loss Drug

Novo Nordisk (NYSE:NVO) Rises on Healthy Q3 Performance

Coca-Cola (NYSE:KO): Enjoy a Refreshing Warren Buffett Stock

Eli Lilly Slumps on New Obesity Drug Plans

NVO, LLY, AZN: 3 “Strong Buy” Stocks to Bet on Weight-Loss Drugs

Johnson & Johnson (NYSE:JNJ) Predicts Short-Term Decline for Obesity Drugs

New Plans to Buy a Hypertension Drug Send Novo Nordisk (NYSE:NVO) on the Decline

Novo Nordisk (NYSE:NVO) Buys Hypertension Drug for $1.3 Billion

UBS Calls DaVita (NYSE:DVA) Sell-Off “Big Overreaction”